The unexpected evolution of myocardial injury while infected with the coronavirus: A COVID-19 case report

J T Doran1,2

  • 1Jean Doran Biokineticist, Letterkenny, Derry and Strabane, Ireland and United Kingdom.

Insights

This case study details a patient with coronavirus disease 2019 (COVID-19) who experienced atypical cardiac symptoms, including T wave inversion on ECG. Early recognition and a coordinated approach are crucial for managing these cardiovascular complications.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Virology

Background:

  • The emergence of a novel coronavirus in December 2019 led to a global pandemic, initially recognized for respiratory symptoms.
  • This virus has been associated with cardiovascular complications, including acute myocardial injury and chronic cardiac damage.

Observation:

  • A patient presented with symptoms suggestive of mild myocarditis or pericarditis, an atypical manifestation of coronavirus disease 2019 (COVID-19).
  • Initial symptoms persisted, leading to emergency department visits and subsequent diagnostic procedures.

Findings:

  • Reverse transcription polymerase chain reaction (RT-PCR) confirmed a ribonucleic acid (RNA) viral infection, diagnosing the patient with coronavirus disease 2019 (COVID-19).
  • An electrocardiograph (ECG) performed 27 days post-infection revealed T wave inversion, indicating cardiac involvement.

Implications:

  • This case underscores the importance of a multidisciplinary approach for managing unexpected patient recovery patterns in COVID-19.
  • Developing cardiac-protective strategies and supportive measures is essential for combating viral infections with cardiovascular sequelae.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
17
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
17
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
31
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
20
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
27